Sharp Therapeutics Corp SHRXF
$1.00
Last Updated: Aug 06, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
SHRXF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Sharp Therapeutics Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Sharp Therapeutics Corp. Stock Analysis SHRXF
United States Health Care Nano Cap Sharp Therapeutics Corp. operates as a biology technology company, which engages in research and development of therapeutic treatment for genetic diseases. The company is headquartered in Pittsburgh, Pennsylvania. The company went IPO on 2023-08-04. Its discovery platform combines high throughput screening technologies, with compound libraries computational optimized based on the physics and biology of cellular trafficking defects and allosteric activation of proteins. The platform produces small molecule compounds that restore activity in mutated proteins giving the potential to treat genetic disorders with conventional pill-based medicines. Its technology includes CoreX assay technology, AlloChem compound libraries, and mine data system and machine learning layer. Its advanced programs include a small molecule that prevents the degradation of the neuroprotective protein progranulin, thus increasing progranulin levels preventing neurodegeneration, and a small molecule that restores activity of mutated GCase protein (mutation and loss of activity of GCase is the genetic cause of Gaucher’s disease).
Sharp Therapeutics Corp (SHRXF) Chart
Financial Metrics & Statements of Sharp Therapeutics Corp (SHRXF)
FAQ's for Sharp Therapeutics Corp (SHRXF)
- As of August 2026, Sharp Therapeutics Corp SHRXF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sharp Therapeutics Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Sharp Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Sharp Therapeutics Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Sharp Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Sharp Therapeutics Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Sharp Therapeutics Corp (SHRXF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
